Arcus Biosciences Inc. (RCUS)
NYSE: RCUS
· Real-Time Price · USD
8.55
0.01 (0.12%)
At close: May 15, 2025, 3:59 PM
8.98
4.97%
Pre-market: May 16, 2025, 05:33 AM EDT
Arcus Biosciences Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|
| Other Collaboration Revenue Revenue | 36M | 37M | 33M |
| Other Collaboration Revenue Revenue Growth | -2.70% | +12.12% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 28M | 28M | 30M | 28M | 32M | 29M | 30M | 28M | 30M | 28M | 26.29M | 25.84M | 23.97M | 23.3M | 16.34M | 16.83M | 15.82M | 12.79M | 11.18M | 11.43M | 7.01M | 6.59M | 7.76M | 5.91M | 4.97M | 3.61M | 3.58M | 3.45M | 2.93M | 2.45M | 1.86M | 1.83M | 1.5M |
| Selling, General, and Administrative Revenue Growth | 0.00% | -6.67% | +7.14% | -12.50% | +10.34% | -3.33% | +7.14% | -6.67% | +7.14% | +6.49% | +1.77% | +7.77% | +2.91% | +42.54% | -2.87% | +6.35% | +23.73% | +14.40% | -2.23% | +63.13% | +6.33% | -15.04% | +31.25% | +18.96% | +37.65% | +0.92% | +3.68% | +17.79% | +19.65% | +31.47% | +1.75% | +22.33% | n/a |
| Research and Development Revenue | 122M | 101M | 123M | 115M | 109M | 93M | 82M | 84M | 81M | 80M | 76.68M | 69.91M | 61.21M | 49.94M | 71.25M | 68.77M | 66.39M | 48.71M | 51.8M | 35.69M | 23.14M | 20.69M | 17.24M | 25M | 15.55M | 11.44M | 12.86M | 13.7M | 11.65M | 12.15M | 21.43M | 7.83M | 5.8M |
| Research and Development Revenue Growth | +20.79% | -17.89% | +6.96% | +5.50% | +17.20% | +13.41% | -2.38% | +3.70% | +1.25% | +4.32% | +9.70% | +14.20% | +22.58% | -29.92% | +3.61% | +3.59% | +36.28% | -5.96% | +45.13% | +54.23% | +11.87% | +19.98% | -31.03% | +60.72% | +36.01% | -11.07% | -6.13% | +17.57% | -4.07% | -43.34% | +173.62% | +34.98% | n/a |